Blog

You may have been taken by surprise earlier this month when a new pharmaceutical stock landed in your portfolio that you didn't know you bought -- Viatris (NASDAQ: VTRS).

It may seem like a new

No one could have predicted the violent swings and sheer unpredictability of the 2020 stock market. While investors know to expect a certain amount of risk when trading stocks, the market's journey

Image source: Getty Images.

While it doesn't influence our opinions of products, we may receive compensation from partners whose offers appear here. We're on your side, always. See our full

Each year, the deadline to file taxes comes on April 15, or on the next business day if the 15th is a holiday or falls on the weekend. That means you're required to file your returns for the 2020

There have been some clear investing trends in 2020 -- IPOs, SPACs, and electric vehicle stocks. Tesla (NASDAQ: TSLA) now has a market cap above $600 billion and investors are very excited about the

No matter how you look at it, Pfizer (NYSE: PFE) has had a remarkable year in 2020. The big drugmaker made a critical decision early on to team up with German biotech BioNTech (NASDAQ: BNTX) on

One of the strangest years on record for the stock market is ending. When we eventually cross the finish line in nine calendar days, it'll potentially be with the major U.S. indexes at or very close

Whether you're thinking of claiming Social Security in 2021 or not, the moves you make in the coming year could dictate how much money you ultimately receive from the program as a senior. If your

You can't turn back the hands of time, but it would be pretty cool if you could.

Anyone who has paid attention to the news this year has no doubt heard quite a bit about Moderna (NASDAQ: MRNA). The

Image source: Getty Images.

While it doesn't influence our opinions of products, we may receive compensation from partners whose offers appear here. We're on your side, always. See our full

In just nine days, we'll close the curtain on one of the craziest years in history. The broad-based S&P 500 endured a record-setting bear market decline of 34% in under five weeks. The index then

We all want to leave as much as to our heirs as possible, without them having to pay taxes on that inheritance. How can you ensure what's best for them after you'll be gone? In this video from an

Image source: The Motley Fool.

Vince Holding (NYSE: VNCE)Q3 2020 Earnings CallDec 21, 2020, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

The bitcoin rally has faded for now. According to CoinDesk, bitcoin hit an all-time high of $24,273 on Sunday, but it's pulled back about 6% as of this writing. But even though bitcoin is down

In this episode of Industry Focus: Wildcard, Emily Flippen and Motley Fool contributor Brian Feroldi do a deep dive into Butterfly and talk about how the company is revolutionizing the medical

Major cruise company Royal Caribbean Group (NYSE: RCL) announced today it is creating a $40 million fund to provide loans to travel agents struggling with the COVID-19 pandemic and its economic

Fresh off receiving its crucial emergency use authorization (EUA) in the U.S., Pfizer (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) coronavirus vaccine has received similar approval in Europe.

Both

Connected-fitness company Peloton Interactive (NASDAQ: PTON) agreed to acquire fellow fitness company Precor after the market closed on Monday. The $420 million acquisition expands Peloton's

Marijuana stock Aphria (NASDAQ: APHA) declined notably on Monday, shedding almost 5.8% of its value. While investors have already digested last week's news of the company's merger with peer Canadian

A coronavirus vaccine candidate similar to that of recently approved ones from Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) and Moderna (NASDAQ: MRNA) has now moved into late-stage testing on

FibroGen (NASDAQ: FGEN) isn't starting the week out very well. On Monday, investors pushed down its stock price by 9%. This seems to be punishment for the company's after-market announcement the

Shares of Gevo (NASDAQ: GEVO) were climbing today after the alternative fuel specialist announced that it had exercised an option to purchase 239 acres of land in South Dakota, capitalizing on an

In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Bill Barker about the latest headlines and earnings reports from Wall Street. They discuss the antitrust lawsuit against a

Image source: Getty Images.

While it doesn't influence our opinions of products, we may receive compensation from partners whose offers appear here. We're on your side, always. See our full

The stock market spent much of Monday sharply lower, with investors initially reacting poorly to news of a new strain of coronavirus in the U.K. and nervousness about whether the stimulus package